Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner
Compose a Response to This Article
Other responses
No responses have been published for this article.
